BioLargo’s Clyra Medical selects Keystone Industries for manufacturing support

BioLargo announced that its subsidiary Clyra Medical Technologies has selected Keystone Industries to support manufacturing of its medical products. The relationship focuses on the build-out of scaled manufacturing capacity for Clyra’s FDA 510(k) cleared Bioclynse surgical wound irrigation solution. Clyra and Keystone have been and continue to make significant investments to support the launch of Bioclynse. Bioclynse is Clyra’s FDA 510(k) cleared, safe, highly effective, broad spectrum wound irrigation solution with enormous potential to improve patient outcomes in applications like orthopaedic surgery and dentistry